Franken, Margreet G <br/><br/>
Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands.  [electronic resource] 

 -  Anti-cancer drugs  07 2018 
 - 579-588 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000628  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Drug Costs<br/>Female<br/>Health Care Costs<br/>Humans<br/>Ipilimumab--economics<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Netherlands<br/>Registries<br/>Skin Neoplasms--drug therapy<br/>Melanoma, Cutaneous Malignant